MSL-KOL Engagement

Strengthening MSL and KOL Interactions in a Changing Healthcare Landscape

July 25, 2025 – 6 min read

Medical Science Liaisons (MSLs) play a vital role in how scientific innovation reaches healthcare providers and ultimately benefits patients. Their job isn’t just to share information—it’s to lead scientific conversations, shape clinical understanding, and help decision-makers apply the latest research to real‑world care.

That work is more important—and more complex—than ever. It’s not enough to show up with clinical data. MSLs need to know how to engage with confidence, deliver insights that matter, and adapt to different HCP preferences while staying grounded in scientific integrity.

What Makes the MSL Role Strategic

MSLs bring value in ways no one else in the organization can. They’re not selling a product—they’re guiding how science is understood and applied. When done right, their conversations can influence clinical practice, inform treatment decisions, and support better outcomes.

They help shape the scientific direction of a therapy’s use, ensuring new evidence is not only communicated but understood in the right context. This is especially critical when launching a new product, expanding indications, or responding to shifts in the treatment landscape.

MSLs are also the face of the company to KOLs and HCPs. Their ability to interpret scientific data and link it to practical, clinical needs is what builds credibility. That credibility fuels trust—and trust is what drives long-term, high‑value relationships.

It’s not enough to show up with clinical data. MSLs need to know how to engage with confidence, deliver insights that matter, and adapt to different HCP preferences while staying grounded in scientific integrity.

Four Areas Where MSLs Can Have Greater Impact

1. Confidence and Clarity in Scientific Dialogue

MSLs often operate in high-stakes conversations where clinical nuance and credibility matter. Confidence in delivery—combined with the ability to make complex science clear—is what sets strong MSLs apart.

That kind of presence doesn’t happen by accident. It comes from planning, practice, and preparation. Anticipating questions, rehearsing messaging, and getting feedback from peers or mentors can make a big difference.

It’s all about being ready to engage with purpose, answer tough questions, and handle complex conversations with composure.

2. Tailoring the Data to Fit the Conversation

HCPs aren’t looking for a clinical data dump. They want to know what’s relevant to their practice and their patients. That means MSLs need to know how to connect the dots—how to present the data in a way that’s useful, timely, and aligned with the clinician’s focus.

MSL leaders often refer to the importance of Clinical Storytelling—not in the commercial sense, but as a way to move beyond raw data and illustrate the real-world impact of a therapy. It’s about crafting a narrative that highlights how the science translates into meaningful change in patients’ lives.

Some MSLs may balk at the term, thinking it sounds too “commercial” —but the core idea remains: make the science resonate. MSLs who frame their message to fit the disease state, therapeutic goals, or patient population are more likely to influence behavior. The science is the same, but the dialogue changes depending on who’s listening.

MSLs who frame their message to fit the disease state, therapeutic goals, or patient population are more likely to influence behavior.

3. Adapting to Different Engagement Styles

Not every interaction happens the same way. Some KOLs prefer in-person meetings. Others want quick updates via email or video call. Some want deep dives; others want high-level insights they can act on.

MSL leaders often point to Emotional Intelligence as the differentiator here—the ability to read the room (or screen), understand what the HCP needs, and adapt in real time. It’s not just about what’s being shared, but how it’s being shared.

The ability to flex, while still delivering value, is essential. MSLs need tools, strategies, and support that help them navigate different formats without losing impact. Whether it’s face-to-face, virtual, or asynchronous, the goal is always the same: make the interaction count.

4. Learning from the Field and Evolving the Approach

Every KOL conversation is an opportunity—not just to share insights, but to learn. What questions are being asked? Where is there confusion or hesitation? What feedback can be brought back to medical affairs, R&D, commercial, or other client-facing roles?

The best MSLs are constantly refining their approach. Organizations can support this by creating spaces for reflection, coaching, and peer learning. Brief, in-the-moment tools or huddles can keep skills sharp and help MSLs stay in sync with the field’s needs.

What About Hybrid Roles?

Some companies are exploring hybrid roles that combine the scientific depth of an MSL with broader customer engagement skills. The goal: to reduce the burden of time-strapped HCPs by streamlining touchpoints and delivering cohesive, high-value conversations—all grounded in scientific credibility.

These roles aren’t sales reps in disguise. They’re designed to meet diverse HCP needs through clinical expertise, strong communication, and system-level awareness. As care models grow more complex, this integrated approach will be key to building trust and driving meaningful dialogue.

Success in these roles hinges on communication—listening closely, tailoring messages, and navigating complex clinical conversations with clarity.

How Organizations Can Support MSL Success

While MSLs are experts in their field, they still need structured support to perform at their best. That support should reflect the unique nature of their work—not be repurposed sales training or generic communication programs.

What works well:

  • Therapeutic-area-specific sprint plans that help focus engagement across priority accounts and evidence narratives 
  • Call planning tools designed for scientific exchange, not sales messaging 
  • Clinical storytelling techniques that elevate the quality of dialogue, making complex science accessible and relevant 
  • Coaching frameworks built around real-world scientific conversations, not scripts or pitches 
  • Reinforcement in the flow of work—bite-sized, 5-10 minute content that MSLs can apply immediately in the field
  • Ongoing focus on the call continuum—from pre-call planning to capturing insights and determining follow-ups 
  • Leader enablement to provide regular, relevant coaching—not oversight, but support 
  • Accountability through meaningful metrics—not just call counts, but measures like actionable insights shared, quality of follow-up, and influence mapping 

In Sum

MSLs are central to how new science gets adopted in practice. They help shape how HCPs understand innovation, navigate treatment decisions, and deliver care. Their conversations matter—not just to the company, but to patients.

That impact can’t be left to chance. When MSLs are equipped to lead scientific dialogue with clarity, confidence, and adaptability, the entire organization benefits. And so do the clinicians and patients they ultimately serve.

In this Performance Minute, Rich Mesch from Performance Development Group challenges the way most life sciences teams measure success.

Never Miss an Article from PDG